Delivery Order V797P2140D-36C24920N0477

The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $27,000 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule to provide FEIBA from August 18th to September 30th, 2023. As the prime contractor, Takeda will deliver the Factor Eight Inhibitor Bypassing Activity product to support VHA's care of veterans in Veterans Integrated Service Network 21, headquartered in Lexington, Massachusetts. No subcontractors...

This is a delivery order awarded by the Department of Veterans Affairs Veterans Integrated Service Network 20 to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company, for the emergency procurement of FEIBA anti-inhibitor coagulant complex vials for the Portland VA Medical Center. The order was placed against Baxalta's existing GSA Pharmaceutical and Drugs Schedule contract and has a firm-fixed price ceiling value of $75,839.40. No set-aside designation was used for this award....

This is a federal contract award to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, by the Veterans Integrated Service Network 7 of the Department of Veterans Affairs. The contract award, with a ceiling value of $110,361.60, is for the delivery of FEIBA, a pharmaceutical product, under the GSA Pharmaceuticals and Drugs schedule contract. The contract is a firm fixed-price delivery order with an ultimate completion date of October 26, 2016. No set-aside designation was used...

This is a delivery order awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The $10,114.20 firm fixed-price contract is for the supply of ADVATE, a specialty medication used to treat hemophilia. This award falls under Takeda's existing Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, valued at $19,472,334.90, which facilitates the...

This is a delivery order awarded by the Federal Medical Center Devens, a civilian federal agency, to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $84,886.42 firm fixed-price contract provides a monthly supply of the pharmaceutical Kogenate FS, which is used to treat hemophilia, off of the Federal Supply Schedule (FSS) contract V797P-2202D for Pharmaceuticals and Drugs. The contract had no set-aside designation and was awarded on January 28, 2016,...

The Defense Logistics Agency awarded a $41,605.34 delivery order to AmerisourceBergen Drug Corp for the supply of 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. The contract, which became effective on September 15, 2025, with completion targeted for September 16, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...

The Defense Logistics Agency (DLA) awarded a $11,854.88 delivery order to AmerisourceBergen Drug Corp for the supply of 50 mg vials of Activase, a tissue plasminogen activator used for thrombolytic therapy in acute medical emergencies. This firm fixed-price delivery order, issued on December 6, 2024, with an ultimate completion date of December 9, 2024, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled...

The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a $210,000.00 firm-fixed-price delivery order contract to Baxalta US Inc., a foreign-owned for-profit pharmaceutical company, to provide ADVATE, a specialty drug for the treatment of hemophilia. The contract is under Baxalta's General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract. No set-aside designation was used. Baxalta has previously provided other specialty...

The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $9,763 firm fixed price delivery order for 1,000 vial units of KCENTRA under an unidentified contracting vehicle. The place of performance is Park Ridge, Illinois and all items are to be delivered by March 23, 2022. KCENTRA is a plasma-derived four-factor prothrombin complex concentrate used to treat patients with acquired deficiencies of prothrombin complex coagulation factors due to warfarin or similar vitamin K antagonist...

The Defense Logistics Agency awarded a delivery order valued at $14,329.10 to AmerisourceBergen Drug Corp for 20,000-unit vials of Thrombin-JMI, a hemostatic agent used in surgical and medical applications. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...